Drugs / RAYOS
last change Jun 2020 re-read 3 minutes ago

RAYOS

Developed for
systemic lupus erythematosus
Investigated by
Ampel BioSolutions, LLC

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03098823 Sep 2017 → May 2019 systemic lupus erythematosus Ampel BioSolutions, LLC Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RAYOS ClinicalTrials.gov intervention name — accepted as the source's own label NCT03098823 ↗